Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan 15;87(2):220-8.
doi: 10.1016/j.bcp.2013.10.028. Epub 2013 Nov 20.

GHB receptor targets in the CNS: focus on high-affinity binding sites

Affiliations
Review

GHB receptor targets in the CNS: focus on high-affinity binding sites

Tina Bay et al. Biochem Pharmacol. .

Abstract

γ-Hydroxybutyric acid (GHB) is an endogenous compound in the mammalian brain with both low- and high-affinity receptor targets. GHB is used clinically in the treatment of symptoms of narcolepsy and alcoholism, but also illicitly abused as the recreational drug Fantasy. Major pharmacological effects of exogenous GHB are mediated by GABA subtype B (GABAB) receptors that bind GHB with low affinity. The existence of GHB high-affinity binding sites has been known for more than three decades, but the uncovering of their molecular identity has only recently begun. This has been prompted by the generation of molecular tools to selectively study high-affinity sites. These include both genetically modified GABAB knock-out mice and engineered selective GHB ligands. Recently, certain GABA subtype A (GABAA) receptor subtypes emerged as high-affinity GHB binding sites and potential physiological mediators of GHB effects. In this research update, a description of the various reported receptors for GHB is provided, including GABAB receptors, certain GABAA receptor subtypes and other reported GHB receptors. The main focus will thus be on the high-affinity binding targets for GHB and their potential functional roles in the mammalian brain.

Keywords: (2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid; 3-hydroxycyclopent-1-enecarboxylic acid; 4-hydroxy-4-[4-(2-iodobenzyloxy)phenyl]butanoate; 4-hydroxy-4-methylpentanoic acid; 4-hydroxy-4-naphtylbutanoic acid; 5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-yl ethanoic acid; BnOPh-GHB; DS; G protein-coupled receptor; GABA; GABA subtype A; GABA subtype B; GABA(A); GABA(A) receptor; GABA(B); GABA(B) knock-out mice; GBL; GHB; GHB receptor; GPCR; HOCPCA; KO; MAPK; NCS-356; NCS-382; NCS-400; NCS-435; PERV; SSADH; SWD; T-HCA; TM; UMB68; UMB86; WT; discriminative stimulus; knock-out; mitogen-activated protein kinase; porcine endogenous retrovirus; spike-and-wave discharge; succinic semialdehyde aldehyde dehydrogenase; trans-4-hydroxycrotonic acid; transmembrane; wild-type.; γ-(p-chlorobenzyl)-γ-hydroxybutanoic acid; γ-(p-methoxybenzyl)-γ-hydroxybutanoic acid; γ-aminobutyric acid; γ-butyrolactone; γ-hydroxybutyric acid.

PubMed Disclaimer

Publication types

MeSH terms